OUTCOMES AT 3 YEARS IN EBV plus EUROPEAN SUBPOPULATIONS FROM BENEFIT AND BENEFIT-EXT

被引：0
|
作者：
Budde, K. [1 ]
Blancho, G. [2 ]
Merville, P. [3 ]
Moal, M. -C. [4 ]
Rostaing, L. [5 ]
Harler, M. B. [6 ]
Grinyo, J. [7 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Univ Hosp Nantes, Nantes, France
[3] CHU Bordeaux, Bordeaux, France
[4] CHU Brest, F-29285 Brest, France
[5] CHU Toulouse, Toulouse, France
[6] Bristol Myers Squibb Co, Princeton, NJ USA
[7] Hosp Univ Bellvitge, Barcelona, Spain
来源：
TRANSPLANT INTERNATIONAL | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P030
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] Outcomes at 3 Years in EBV plus European Subpopulations From BENEFIT and BENEFIT-EXT
    Blancho, G.
    Budde, K.
    Merville, P.
    Moal, M.
    Rostaing, L.
    Harler, M.
    Grinyo, J.
    TRANSPLANTATION, 2014, 98 : 455 - 455
  • [2] Outcomes at 3 Years in EBV plus European Subpopulations From BENEFIT and BENEFIT-EXT
    Blancho, G.
    Budde, K.
    Merville, P.
    Moal, M.
    Rostaing, L.
    Harler, M.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 455 - 455
  • [3] Outcomes at 3-Years in EBV plus Recipients of UNOS Criteria ECD Kidneys From a Randomized Trial (BENEFIT-EXT) Comparing Belatacept vs Cyclosporine
    Durrbach, A.
    Muehlbacher, F.
    Florman, S.
    Medina Pestana, J.
    Jones-Burton, C.
    Charpentier, B.
    TRANSPLANTATION, 2014, 98 : 456 - 457
  • [4] OUTCOMES AT 3-YEARS IN EBV plus RECIPIENTS OF UNOS CRITERIA ECD KIDNEYS FROM A RANDOMIZED TRIAL (BENEFIT-EXT) COMPARING BELATACEPT VERSUS CYCLOSPORINE
    Durrbach, A.
    Muehlbacher, F.
    Florman, S.
    Pestana, J. Medina
    Polinsky, M.
    Charpentier, B.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 7 - 7
  • [5] Outcomes at 3-Years in EBV plus Recipients of UNOS Criteria ECD Kidneys From a Randomized Trial (BENEFIT-EXT) Comparing Belatacept vs Cyclosporine
    Durrbach, A.
    Muehlbacher, F.
    Florman, S.
    Pestana, J. Medina
    Jones-Burton, C.
    Charpentier, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 456 - 457
  • [6] Outcomes at 3-years in EBV plus Recipients of UNOS Criteria ECD Kidneys from a Randomized Trial (BENEFIT-EXT) Comparing Belatacept vs Cyclosporine
    Muehlbacher, Ferdinand
    Durrbach, Antoine
    Florman, Sander
    Pestana, Jose Medina
    Polinsky, Martin
    Charpentier, Bernard
    SWISS MEDICAL WEEKLY, 2014, 144 : 24S - 24S
  • [7] Outcomes at 3-years in EBV plus Recipients of Deceased Donor Kidneys from Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
    Muehlbacher, Ferdinand
    Durrbach, Antoine
    Florman, Sander
    Pestana, Jose Medina
    Harler, Mary Beth
    Larsen, Christian
    SWISS MEDICAL WEEKLY, 2014, 144 : 23S - 23S
  • [8] Outcomes at 3-Years in EBV plus Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
    Muehlbacher, F.
    Durrbach, A.
    Florman, S.
    Medina Pestana, J.
    Harler, M.
    Larsen, C.
    TRANSPLANTATION, 2014, 98 : 455 - 455
  • [9] OUTCOMES AT 3-YEARS IN EBV plus RECIPIENTS OF DECEASED DONOR KIDNEYS FROM TWO RANDOMIZED TRIALS (BENEFIT AND BENEFIT EXT) COMPARING BELATACEPT VERSUS CYCLOSPORINE
    Durrbach, A.
    Muehlbacher, F.
    Florman, S.
    Pestana, J. Medina
    Harler, M. B.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 7 - 7
  • [10] Outcomes at 3-Years in EBV plus Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
    Muehlbacher, F.
    Durrbach, A.
    Florman, S.
    Medina Pestana, J.
    Harler, M.
    Larsen, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 455 - 455
12345